Oxaliplatin-d10 - CAS 1132819-16-9

Oxaliplatin-d10 is intended for use as an internal standard for the quantification of oxaliplatin by GC- or LC-MS. Oxaliplatin is a platinum-containing DNA-crosslinking agent. It induces the formation of DNA inter- and intrastrand crosslinks and DNA-protein adducts, inhibits DNA and RNA synthesis, and induces apoptosis in cancer cells. Oxaliplatin is cytotoxic to cisplatin-sensitive A2780 (1A9) and KB-3-1 cells and cisplatin-resistant A2780-E (80) and KB-CP20 cells (IC50s = 0.12, 0.39, 4.7, and 2.7 μM, respectively) . It reduces tumor growth in an HCCLM3 mouse xenograft model when administered at doses of 5 or 10 mg/kg once per week. Formulations containing oxaliplatin have been used in the treatment of advanced colorectal cancer and as adjuvants in stage III colon cancer.

Apoptosis, DNA/RNA Synthesis

DNA Damage/DNA Repair, Apoptosis, Cell Cycle/Checkpoint

1132794

C8H4D10N2O4Pt

407.35

O=C1[O-][Pt+2]2([NH2][C@]3([C@]([NH2]2)(C(C(C(C3([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])[2H])[2H])[O-]C1=O

-20°C

Ice Packs

Isotope products